Biggest News Aggregation in the World
📰 Solstice Trial News

Solstice Trial News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Solstice Trial. Real-time updates on events, politics, business and more.

U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treatment

Takeda Pharmaceutical Company Limited U.S. Food & Drug Administration Grants Priority Review of Maribavir for the Treatment of Post-Transplant Recipients With Cytomegalovirus Infection in Those Resistant and/or Refractory to Prior Anti-CMV Treat Saturday, May 22, 2021 10:31AM IST (5:01AM GMT)   Osaka, Japan:    − If Approved, Maribavir Will Be the First and Only Treatment Indicated for Post-Transplant Cytomegalovirus (CMV) Infecti...
United States Fred Hutch Michael Boeckh Ryoko Matsumoto Maribavir Global Program Leader Human Cytomegalovirus Nuclear Egress

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science